Charles River, 's-Hertogenbosch, The Netherlands.
BASF SE, Ludwigshafen am Rhein, Germany.
Reprod Toxicol. 2018 Sep;80:126-130. doi: 10.1016/j.reprotox.2018.04.017. Epub 2018 May 2.
In recent years several OECD test guidelines have been updated and some will be updated shortly with the requirement to measure thyroid hormone levels in the blood of mammalian laboratory species. There is, however, an imperative need for clarification and guidance regarding the collection, assessment, and interpretation of thyroid hormone data for regulatory toxicology and risk assessment. Clarification and guidance is needed for 1) timing and methods of blood collection, 2) standardization and validation of the analytical methods, 3) triggers for additional measurements, 4) the need for T4 measurements in postnatal day (PND) 4 pups, and 5) the interpretation of changes in thyroid hormone levels regarding adversity. Discussions on these topics have already been initiated, and involve expert scientists from a number of international multisector organizations. This paper provides an overview of existing issues, current activities and recommendations for moving forward.
近年来,一些经合组织的测试指南已经更新,其中一些将很快更新,要求测量哺乳动物实验物种血液中的甲状腺激素水平。然而,对于监管毒理学和风险评估中甲状腺激素数据的收集、评估和解释,迫切需要澄清和指导。需要澄清和指导的方面包括:1)采血的时间和方法,2)分析方法的标准化和验证,3)额外测量的触发因素,4)在出生后第 4 天(PND4)幼崽中测量 T4 的必要性,以及 5)关于逆境的甲状腺激素水平变化的解释。已经就这些主题展开了讨论,涉及来自多个国际多部门组织的专家科学家。本文概述了现有问题、当前活动以及推进工作的建议。